In 1975, Teele and colleagues1identified the risk factors for and occurrence of bacteremia in young febrile children presenting to a pediatric walk-in clinic. They found that 3.2% of children 4 weeks to 2 years of age were bacteremic and that the height of the temperature and white blood cell count were valuable predictors of bacteremia. The Teele report initiated a controversy regarding the management of young febrile children that continues today. Despite more than 20 years of research, the essential question remains unchanged—does obtaining a blood culture and initiating expectant therapy with oral or parenteral antibiotics prevent serious sequelae? In this issue of Pediatrics, Kramer and Shapiro2 argue that recently published guidelines for management of febrile children,3 which recommend blood culture and expectant therapy in infants and children with temperatures ≥39°C, are costly, intrusive, and do more harm than good.2 Good clinical practice guidelines have important attributes, including validity, reliability, and scheduled reviews.4 Since the publication of the fever guidelines there have been two developments that may affect their validity. First, there has been a dramatic reduction in the number of cases of meningitis, sepsis, and bacteremia specifically attributable to Haemophilus influenzae type B (Hib).5 The issue of expectant therapy and reduction in morbidity is now largely …
Read full abstract